BioNTech, Pfizer Gain As EU, Australia Seek More Covid Vaccine Doses By Investing.com
By Dhirendra Tripathi Investing.com – Shares of both BioNTech (NASDAQ:BNTX) and Pfizer (NYSE:PFE) rose Friday following a Reuters report that the two companies, which have jointly developed a Covid-19 vaccine, could get to supply another 1.8 billion does to the EU. In another boost for them, Australia has doubled its order for their vaccine to 40 million doses. BioNTech shares rose more than 5% while Pfizer gained 1%. Reuters said the European Commission is seeking EU governments' approval to launch talks with Pfizer and BioNTech for the purchase of the vaccines to be...
Подробнее